Maged Shenouda

Affiliations

  • Chief Financial Officer at Relmada Therapeutics Inc. (RLMD), 2025-05-20
  • Chief Financial Officer at Azurrx Biopharma Inc. (AZRX), 2019-01-02
  • Director at Protea Biosciences Group Inc. (PRGB), 2016-01-07
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
RLMD $0.52 60,000 $31,422.00 288,335 2025-05-20 Filing
RLMD $0.49 90,000 $43,686.00 228,335 2025-05-19 Filing
RLMD $0.44 50,000 $22,100.00 138,335 2025-05-16 Filing
RLMD $2.95 24,120 $71,154.00 88,335 2024-09-11 Filing
RLMD $2.73 21,118 $57,652.14 64,215 2024-09-10 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
RLMD $35.11 2,373 $83,313.42 2,228 2021-03-10 Filing
RLMD $36.02 1,800 $64,836.00 4,601 2021-03-09 Filing
RLMD $35.42 5,727 $202,857.21 6,401 2021-03-09 Filing
RLMD $35.00 100 $3,500.00 12,128 2021-03-08 Filing
RLMD $34.67 1,400 $48,544.44 2,228 2021-02-24 Filing